Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Comment by Timetravel1on Feb 06, 2019 8:11pm

141 Views

Post# 29329578

RE:This is Important

Bump

skyplt wrote: Reluctant to post, but this is material.

To those longs I learned to respect here, I jump back on to share this direct cut and paste from the SEC document filed by APHA this evening:

OTHER MATERIAL INFORMATION

On December 6, 2018, Aphria announced that the Aphria Board appointed the Special Committee to review Aphria’s previously completed acquisition of LATAM Holdings Inc. The Aphria Board expects to receive a report from the Special Committee on or before February 28, 2019.

Except as disclosed in this Directors’ Circular, there is no information that is known to Aphria’s directors and officers that would reasonably be expected to affect the decision of Aphria Shareholders to accept or reject the Hostile Bid.